- Dr. Noon CKD_Korea MFDS : [Product Name] DrNoon CKD / Approved for clinical trial protocol (Jan. 2024) and designated as a Breakthrough Device (Aug. 2023) by the Ministry of Food and Drug Safety of Korea
*Dr. Noon CKD is under the approval process by MFDS of Korea
AI-powered Solution for Chronic Kidney
Disease Risk Assessment
Dr. Noon CKD is a retina-based AI solution that predicts the future risk of developing chronic kidney disease.
Dr. Noon CKD analyzes the blood vessels in the retina with a simple retinal scan without the need for blood or urine tests and shows the risk of developing chronic kidney disease.
How Dr. Noon CKD works
Discover a simple, seamless process designed for easy integration into clinical workflows.
Follow the step-by-step process of Dr. Noon CKD.
-
STEP 1Eye Scan
Take one picture of each eye to capture the retina.
-
STEP 2Image Upload
The retinal images are uploaded to the healthcare institution’s server or cloud platform.
-
STEP 3AI Analysis
Artificial intelligence automatically
analyzes the images to assess the patient’s risk of chronic kidney disease. -
STEP 4Result Review
The risk of chronic kidney disease is determined through an automatically generated report.
Comparison with
Traditional Methods
A comparison with traditional methods highlights Dr. Noon CKD's superior performance
over conventional tests in assessing cardiovascular risk.
- Blood Test (eGFR)
- Urine Test (ACR)
- Type
- Ease of Use
- Accuracy in Early CKD
- Footprint & Equipment
- Predictive Value
-
Utility in Normal
Kidney Function
- Type Retina-based AI risk prediction
-
Ease of Use
Easy (Simple retinal photo, <3 min)
-
Accuracy in Early CKD
High (Effective in asymptomatic cases)
-
Footprint & Equipment
Small (Requires only fundus camera)
-
Predictive Value
High (Strong performance across populations)
-
Utility in Normal
Kidney FunctionYes (Can predict future CKD risk)
Key Benefits
-
High Accuracy
Provides higher predictive accuracy for chronic kidney disease risk than estimated GFR (eGFR), the current standard kidney function test.
-
Safe & Non-Invasive
Requires no needle injection or radiation exposure, making it comfortable for patients.
-
Fast Test Results
Results are delivered promptly, allowing patients to receive their reports without delay.
-
High Accessibility
It is designed for use in diverse medical settings such as clinics, hospitals, and screening centers, just like standard blood tests.
Publications & Webinars
Check out the clinical validations and related research papers that demonstrate
the accuracy, safety, and real-world effectiveness of Dr. Noon CKD.
-
Original Paper
Non-invasive chronic kidney disease risk stratification tool derived from retina-based deep learning and clinical factors
-
Original Paper
Prediction of systemic biomarkers from retinal photographs: development and validation of deep-learning algorithms
-
Conference Abstract
Retinal Photograph-based Deep Learning Predicts CKD among people with preserved kidney function